What are the best treatments for Retinopathy Of Prematurity?

Retinopathy of Prematurity (ROP) is primarily treated through laser photocoagulation or cryotherapy to destroy avascular peripheral retina, while anti-VEGF injections are increasingly used as a primary or adjunctive therapy. Treatment for Retinopathy of Prematurity must be highly personalized based on the severity of the vascular changes and is managed by specialized pediatric ophthalmologists to prevent retinal detachment and vision loss.

What are the current clinical treatments for Retinopathy of Prematurity?

Management of Retinopathy of Prematurity focuses on arresting the abnormal growth of blood vessels. When the disease reaches "threshold" or "pre-plus/plus" stages, intervention is required. The following approaches are standard in clinical practice:

• Laser Photocoagulation: The current gold-standard treatment for Retinopathy of Prematurity, using a laser to ablate the peripheral, non-vascularized retina.


• Anti-VEGF Therapy: Intravitreal injections of medications like bevacizumab (Avastin) are used to inhibit vascular endothelial growth factor, which drives the abnormal vessel growth seen in Retinopathy of Prematurity.


• Surgical Intervention: In advanced cases (Stage 4 or 5) where retinal detachment occurs, vitrectomy or scleral buckling may be necessary to preserve or restore vision.

Which specialists are involved in the care team?

A multidisciplinary approach is essential for infants diagnosed with Retinopathy of Prematurity. The core care team typically includes a pediatric ophthalmologist, a neonatologist who manages the infant's systemic health, and a pediatric retina specialist. Additionally, a low-vision therapist or an occupational therapist may be involved if permanent visual impairment occurs, ensuring the child receives proper early intervention services.

How does treatment effectiveness vary?

The prognosis for Retinopathy of Prematurity depends heavily on the stage of the disease at the time of diagnosis and the timing of the intervention. While most infants with mild Retinopathy of Prematurity experience spontaneous regression without treatment, those with aggressive posterior ROP require rapid intervention to prevent permanent blindness. Ongoing monitoring is vital, as late-onset complications like myopia, strabismus, and glaucoma can occur even after successful initial treatment.

Next steps

• Consult with a board-certified pediatric ophthalmologist experienced in neonatal retinal diseases.


• Ensure your infant receives scheduled screening exams according to the American Academy of Pediatrics (AAP) guidelines.


• Join the DiseaseMaps.org community to connect with 15 other members currently navigating the challenges of Retinopathy of Prematurity.


• Discuss current clinical trials regarding novel anti-VEGF agents at ClinicalTrials.gov.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always consult your child's healthcare team for personalized medical decisions.

References

• National Eye Institute (NEI) - Retinopathy of Prematurity Fact Sheet


• NIH Genetic and Rare Diseases (GARD) Information Center


• American Academy of Pediatrics (AAP) - Guidelines for ROP Screening and Treatment


• Orphanet - Retinopathy of Prematurity entry